一项基于血培养调整抗生素治疗急性胆管炎的随机非劣效性试验
该研究在韩国12家三级医院前瞻性纳入轻至中度急性胆管炎且已充分胆道引流的患者,随机分为仅依据血培养结果调整抗生素组与依据血和胆汁培养结果调整抗生素组。结果显示两组器官衰竭发生率无显著差异,仅血培养组抗生素使用时间和住院时间更短。
要点
- 轻至中度急性胆管炎充分胆道引流后,仅依据血培养调整抗生素在器官衰竭方面非劣效于依据血和胆汁培养。
- 仅血培养组抗生素使用时间较对照组缩短1.5天,住院时间缩短1.9天。
- 两组全因死亡率、再干预率无显著差异。
核心结论
- 仅依赖血培养结果管理轻至中度胆管炎是合理的,可能有助于减少不必要的医疗资源使用。
研究设计与样本
- 前瞻性、多中心、非劣效性随机试验,2015年8月至2023年9月在韩国12家三级医院开展,患者按1:1随机分组。
- 对照组依据血和胆汁培养结果给予抗生素,试验组仅依据血培养结果给予抗生素。
- 非劣效界值为10%。
主要发现
- 对照组(n=215)器官衰竭28例(13.0%),试验组(n=213)27例(12.7%),差异-0.350%(95%CI -6.690%至5.990%),p>0.999。
- 对照组死亡率3.3%(7例),试验组2.3%(5例),差异-0.908%(95%CI -4.033%至2.216%),p=0.782。
- 对照组再干预率14.9%(31例),试验组12.2%(26例),差异-2.677%(95%CI -9.155%至3.801%),p=0.504。
- 对照组抗生素疗程12.8±8.0天,试验组11.3±6.5天,差异-1.500天(95%CI -2.840至-0.160),p=0.037。
- 对照组住院时间14.1±11.0天,试验组12.2±9.0天,差异-1.900天(95%CI -0.380至0.000),p=0.046。
临床怎么用
- 对于轻至中度急性胆管炎且已充分胆道引流的患者,可考虑仅依据血培养结果调整抗生素治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study evaluated the adequacy of using blood cultures alone for antibiotic therapy in mild-to-moderate acute cholangitis after adequate biliary drainage. METHODS: A prospective, multi-centre, non-inferiority, randomized trial was conducted from August 2015 to September 2023 across 12 tertiary hospitals in South Korea. Patients were randomly assigned 1:1 to groups. The control group was administered antibiotics based on blood and bile culture results, whereas the experimental group was treated based on blood culture results alone. The primary outcome was the rate of organ failure, assessed by the presence of shock, acute kidney injury, altered mental status, and acute respiratory distress. The secondary outcomes were all-cause mortality, frequency of re-interventions, antibiotic usage duration, and hospital stay. The non-inferiority margin was 10%. RESULTS: Patients in the control group (n = 215) and experimental group (n = 213) were analysed. Organ failure occurred in 28 (13.0%) in the control and 27 (12.7%) in the experimental group (difference: -0.350% [95% CI, -6.690% to 5.990%], p > 0.999). Mortality rates were 3.3% in the control (seven patients) and 2.3% in the experimental group (five patients) (-0.908% [-4.033% to 2.216%], p 0.782). The reintervention rates were 31 (14.9%) in the control and 26 (12.2%) in the experimental groups (-2.677% [-9.155% to 3.801%], p 0.504). The antibiotic therapy duration was different (-1.500 days [-2.840 to -0.160], p 0.037) between the control (12.8 ± 8.0 days) and the experimental groups (11.3 ± 6.5 days), and the hospital stay was different (-1.900 days [-0.380 to 0.000], p 0.046) between the control (14.1 ± 11.0 days) and the experimental groups (12.2 ± 9.0 days). DISCUSSION: This study confirms that relying on blood culture results alone for managing mild-to-moderate cholangitis is reasonable and may help reduce the unnecessary use of medical resources.
引用
- Lee TS, Choi JH, Lee JM, et al. A randomized non-inferiority trial investigating antibiotic adjustments based on blood culture in acute cholangitis. Clin Microbiol Infect. 2025. PMID: 39880122. doi:10.1016/j.cmi.2024.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。